Skip to main content
. 2019 Mar 24;11(3):418. doi: 10.3390/cancers11030418

Figure 1.

Figure 1

Antigen processing and presentation scheme through an antibody-based dendritic cell (DC) targeting vaccination approach. Exogenous antigens are degraded and processed for presentation on DC surface-associated major histocompatibility complex (MHC) II molecules to CD4+ T cells. Endogenous antigens are degraded and processed for presentation on MHC I molecules to CD8+ T cells.